KZIA241115P500
- 0.08
- -0.22-73.33%
Kazia Therapeutics Newsroom
Kazia Therapeutics To Carry Out 1-for-10 Reverse Stock Split On October 28th, 2024
October 16th (Eastern Time) - $Kazia Therapeutics(KZIA.US)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from October 28th,
Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women
Kazia Therapeutics Adjusts ADS Ratio to Boost Nasdaq Listing
Express News | Kazia Therapeutics- Plans to Change Ratio of Adss to One Ads Representing 100 Ordinary Shares
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Kazia Therapeutics Announces Presentation of Promising Phase I Data Evaluating Concurrent Paxalisib and Radiation Therapy in Patients With Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations at the American...
Kazia Therapeutics Announces Presentation of EVT801 Clinical Data at 15th Biennial Ovarian Cancer Research Symposium
Kazia Therapeutics Advances Cancer Treatment Options
Kazia Therapeutics Enters Into Licensing Agreement With QIMR Berghofer
Express News | Kazia Therapeutics Ltd - Receives Exclusive Worldwide License for Pi3K Inhibitor Combinations
Express News | Kazia Executes Licensing Agreement With Qimr Berghofer
KAZIA EXECUTES LICENSING AGREEMENT WITH QIMR BERGHOFER
Kazia Therapeutics Files to Sell $100M of American Depositary Shares
ADRs End Lower; Kazia Therapeutics Ltd. Declines 18%
Kazia Therapeutics KZIA +248% Phase 2/3 Data; Longeveron LGVN +59% RMAT Designation
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Nasdaq Surges 1%; JPMorgan Posts Upbeat Earnings
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Kazia Therapeutics (KZIA) Soars 490% in a Week: Here's Why
Dow Jumps 100 Points; Producer Inflation Surpasses Expectations For June